✦ LIBER ✦

Pegylated interferon α-2a plus ribavirin for decompensated hepatitis C virus-related cirrhosis: relationship between efficacy and cumulative dose

✍ Scribed by Xu, Yan; Qi, Wenqian; Wang, Xu; Zhao, Ping; Zhang, Yonggui; Zhang, Qian; Qin, Shaoyou; Wang, Jiangbin

Book ID: 121728354
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 251 KB
Volume: 34
Category: Article
ISSN: 0106-9543
DOI: 10.1111/liv.12417

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

278 PEGYLATED INTERFERON PLUS RIBAVIRIN:

278 PEGYLATED INTERFERON PLUS RIBAVIRIN: AN EFFICACIOUS AND WELL-TOLERATED TREATMENT REGIMEN FOR HIV-HCVCO-INFECTED PATIENTS WITH HEPATITIS C VIRUS RELATED CIRRHOSIS

✍ M.C. Mendes-Correa; M.H. da Silva; J.F.C. Figueiredo; G. Gryninger; M. Gonzalez; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Efficacy and safety of pegylated interfe

Efficacy and safety of pegylated interferon alpha-2a (40 KD) plus ribavirin for treatment of chronic hepatitis C and cirrhosis in Iranian patients

✍ B. Hajarizadeh; S. Alavian 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Dose comparison study of pegylated inter

Dose comparison study of pegylated interferon-α-2b plus ribavirin in naïve Japanese patients with hepatitis C virus genotype 2: A randomized clinical trial

✍ Tomokazu Kawaoka; Yoshiiku Kawakami; Keiji Tsuji; Hiroyuki Ito; Mikiya Kitamoto; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB

Serum PAI-1 is a novel predictor for res

Serum PAI-1 is a novel predictor for response to pegylated interferon-α-2b plus ribavirin therapy in chronic hepatitis C virus infection

✍ D. Miki; W. Ohishi; H. Ochi; C. N. Hayes; H. Abe; M. Tsuge; M. Imamura; N. Kamat 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB

Variants in interferon-alpha pathway gen

Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial

✍ Tania Mara Welzel; Timothy R. Morgan; Herbert L. Bonkovsky; Deepa Naishadham; Ru 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB 👁 2 views

Combination treatment with pegylated-interferon-alpha (PEG IFN-␣) and ribavirin, the current recommended therapy for chronic hepatitis C virus (HCV) infection, results in a sustained virological response (SVR) in only about half of patients. Because genes involved in the interferon-alpha pathway may

Efficacy and tolerability of rituximab w

Efficacy and tolerability of rituximab with or without PEGylated interferon alfa-2b plus ribavirin in severe hepatitis C virus–related vasculitis: A long-term followup study of thirty-two patients

✍ Benjamin Terrier; David Saadoun; Damien Sène; Jérémie Sellam; Laurent Pérard; Br 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 2 views